Category: Clinical Trial
Clinical Trial market research reports by Frost & Sullivan
-
Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities
Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities The Integration of Real-world Insights into Trial Management is Propelling AI Adoption in Clinical Trials As global clinical pipelines witness a surge in complex novel therapies, there is a general inclinati ... Read More
-
Innovation Waves in Immuno-oncology Therapy Development
Innovation Waves in Immuno-oncology Therapy Development Next-gen Cell Therapies and Precision Immunotherapies are Driving Growth and New Product Development Immuno-oncology (I-O) therapies target tumors by harnessing the host’s immune system. With the growing incidence and prevalence of various type ... Read More
-
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023 More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid- ... Read More
-
Global Decentralized Clinical Trials Growth Opportunities
Global Decentralized Clinical Trials Growth Opportunities Strong Competitive Intensity is Advancing DCT Initiatives Across the World Paving Way for a Partnership-based Growth Model The global decentralized clinical trial (DCT) market has been witnessing a continued surge after the COVID-19 pandemic. ... Read More
-
Growth Opportunities and Innovative Use Cases for AI in Clinical Trials
Growth Opportunities and Innovative Use Cases for AI in Clinical Trials As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gainin ... Read More
-
Global Contract Research Organization (CRO) Growth Opportunities
Global Contract Research Organization (CRO) Growth Opportunities The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were engaged in tremendous efforts to either develop new molecules or repurpose existing therapie ... Read More
-
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases ... Read More
-
Frost Radar™: Global Clinical Trial IT Solutions Market, 2022
Frost Radar™: Global Clinical Trial IT Solutions Market, 2022 COVID-19 has accelerated the need for a faster, more accessible clinical trial process. During the height of the pandemic, in-person follow-ups for ongoing trials were replaced with hand-held devices that essentially built an ecosystem fo ... Read More
-
Growth Opportunities for Digital Twins in Global Healthcare
Growth Opportunities for Digital Twins in Global Healthcare A digital twin (DT) is a simulated clone of a tangible item or an intangible system/process that users can study independent from its real-world counterpart to aid decision-making. DT technology initially saw application in the production a ... Read More
-
Frost Radar™: North American Clinical Documentation Improvement Market, 2022
Frost Radar™: North American Clinical Documentation Improvement Market, 2022 Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processi ... Read More
-
Global Pharmaceuticals Outlook, 2022
Global Pharmaceuticals Outlook, 2022 Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemi ... Read More
-
Global eClinical Solutions Growth Opportunities
Global eClinical Solutions Growth Opportunities The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick ... Read More
Research Assistance
